AskGene is a series b startup based in United States. 1 investor tracked.
Based in the United States, AskGene is a startup founded in 2018. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
AskGene is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel antibody and fusion protein therapeutics for the treatment of cancer and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.